cost was as a result of allowance for doubtful debt of THB 5.495 million because of the introduction of accounting standard TFRS 9 at to company at beginning of this year. As of 31 March ,2020 the

, 2020; - The total assets amounted to 1,694.31 million baht, decreasing by 59.45 million baht or 3.39% from the amount as of December 31, 2019. The decrease was due to the payment received from trade

. 3. The prepayment of the debenture by using proceed from this transaction will help UWC to decrease its interest expenses more than TH 10 million also enhance its debt service ability. 4. Mitigation

. Highlights  Health and safety: There were zero lost time injuries in Q3 2019  Revenue: 220mTHB in Q3 2019 compared to 303mTHB in Q3 2018 a decrease of 27%  EBITDA: 37mTHB in Q3 2019 compared to 55mTHB in Q3

Gross Profit Margin by Segment 29.1 26.8 (2.3) Gross Profit Margin Gross profit for Q1/2023 compared to Q1/2022 slightly decrease 1.1% from Baht 471.6 million to Baht 466.2 million, decrease by Baht 5.4

decrease of 42.9 percent and net profit of Baht 40.13 million or decreased by 50.2% while compared to the same period of last year which the net profit was Baht 80.62 million. Due to the economic downturn in

, decreased by 87.7% YoY and THB 967 million in 6M20, decreased by 51.3% YoY. The main factor of this decrease was from COVID-19 pandemic impact. It has caused the temporary closure of hotel in Thailand and

had the opportunity to export methyl ester amounted to 6,800 tons. Meanwhile, natural fatty alcohols sales volume was sold at 96,946 tons, a decrease of 17,838 tons or 16% from FY2018. The total revenue

17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2

from 1. the group recovering bad debt in 2017 of Baht 3.62 million which led to a decrease in expenses in 2017. However, there was no recovered bad debt in quarter 1/2018. 2. Increase in staff expenses